|Bid||55.48 x 500|
|Ask||55.49 x 900|
|Day's range||55.19 - 55.65|
|52-week range||38.87 - 58.09|
|PE ratio (TTM)||-89.87|
|Earnings date||2 Aug 2017|
|Dividend & yield||1.60 (2.93%)|
|1y target est||60.15|
These are the stocks posting the largest moves before the bell.
Heads of the U.S. financial regulatory agencies will meet behind closed doors next Friday to discuss MetLife Inc's (MET.N) lawsuit against them, according to a notice from Treasury, as the Trump administration wrestles with reforms put in place in response to the financial crisis. The regulators, who comprise the Financial Stability Oversight Council (FSOC), and MetLife both asked earlier this month for another pause in the long-running case in which the country's largest life insurer has challenged the federal government's decision to label it as "too big to fail." The appeals court has not yet said whether it will grant an abeyance. More than a year ago, U.S. District Judge Rosemary Collyer struck down the council's designation of MetLife as "systemically important," which signifies that it could devastate the financial system if it failed and which triggers stricter oversight.
MetLife, Inc. (MET) has officially received all necessary regulatory approvals for the spinoff of Brighthouse Financial. The U.S. Securities and Exchange Commission gave its final stamp of approval for the spinoff Thursday. MetLife’s board of directors previously approved the transaction.